CAR-T Cell Therapy Market Forecast

CAR T Cell Therapy Market is expected to grow with a CAGR of almost 50% in future.

CAR-T Cell Therapy Market Forecast Analyst View: CAR-T Cell Therapy Market is expected to grow with a CAGR of almost 50% in future.

Press Release Title: CAR-T Cell Therapy Market is expected to grow with a CAGR of almost 50% in future.

For more Info: https://www.renub.com/global-car-t-cell-therapy-market-nd.php Report Title: CAR-T Cell Therapy Market Global Forecast by Regions (North America, Europe, Asia Pacific, Latin America, Middle East, Africa), Targeted Antigens (CD19, CD20, GD2, CD22, CD30, CD33, HER2, MESO, EGFRvII, Others) Clinical Trials/Study (CD19, CD20, GD2, CD22, CD30, CD33,HER1, HER2, MESO, EGFRvII) Companies (Novartis,Gilead Sciences (Kite Pharma), Celgene Corporation (Juno Therapeutics), Celyad)

Access Full Research: https://www.renub.com/car-t-cell-therapy-market-p.php

Get Free Customization in this Report © Renub Research

Page 1 of 5

www.renub.com

CAR T Cell Therapy Market is expected to grow with a CAGR of almost 50% in future.

Renub Research recent report on CAR T Cell Therapy Market, anticipate that it will grow at with a CAGR of almost 50% over the period of 2018-2028. Over some years, immunotherapy has emerged as one of the most curative ways in the treatment of cancerous tumors among the cancer community which strengthen the power of patient’s immune system to fight these tumors.

Immunotherapy; adoptive cell transfer (ACT) for cancer treatment is evolving very rapidly adoptive cell transfer (ACT) which includes collection and usage of patient’s own immune cells in the treatment of their cancer. There are various types of adoptive cell transfer (ACT) are being developed namely; TILs, TCRs, and CARs, of which, CARs- CAR T-cell therapy is the only clinical developed advanced approach used in the treatment of cancer.

Request a free sample copy of the report: https://www.renub.com/contactus.php

Over the several years; the surgery, chemotherapy and radiation therapy are considered to be the best available treatment for cancer. Later, targeted therapies such as trastuzumab (Herceptin®) and imatinib (Gleevec®) like drugs which specifically targets cancer cells are being used in the cancer treatment.

CAR-T Cell therapy is a treatment in which a patient’s immune system cell (T cell) are transformed in the clinical laboratory so that the transformed immune system cell will attack cancerous cell in the patient’s body. T cells are usually extracted from the patient’s blood, which is then treated in the laboratory with special receptor known as a chimeric antigen receptor (CAR) and hence, the treatment is termed as CAR T Cell Therapy. © Renub Research

Page 2 of 5

www.renub.com

CAR T Cell Therapy Market is expected to grow with a CAGR of almost 50% in future.

The chimeric antigen receptor (CAR) cells tend to act like an antigen on the cancer cells and kill them. Today, with the advancement in medical technology, a large number of CAR T cells are developed in the laboratory and is given to the cancer patients by infusion, which will certainly drive CAR T Cell Therapy Market to grow vigorously in the coming future with increasing cancer cases worldwide and the fuelling demand for better healthcare services from the consumer.

Recently, the Food and Drug Administration (FDA) has approved two CAR T-cell therapies in 2017 of which one is for the adults with advanced lymphomas and the other for the treatment of children with acute lymphoblastic leukemia (ALL). Nonetheless, the CAR T cells therapy and other forms of ACT are still in its early days and is still being developed and so, the researchers are still cautious about the CAR T cells therapy that will it ever be effective against solid tumors like breast and colorectal cancer.

Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/car-t-cell-therapy-market-p.php

With increasing research and development, the field of CAR T Cell therapy has reached a tipping point. In the recent years, development in the CAR T Cells and other ACT approaches has pushed immensely, as the researchers are developing a better understanding of how these therapies work with cancer patients and translating that outcome into improvements in how they are developed and tested more efficiently.

In the near future; it is believed that medical science will see a dramatic progress which will push all the boundaries that what a people thought was possible with these cell-transfer based treatments.

Key Topics Covered 1.

Executive Summary

2.

Global Chimeric Antigen Receptor (CAR)-T cell Therapy Market

3.

Market Share – CAR-T Cell Therapy 3.1 3.2

4.

By Geographical Region

By Targeted Antigens

Targeted Antigen Market 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 4.10

CD19 CD20 GD2 CD22 CD30 CD33 HER2 Mesothelin (MESO) EGFRvIII Others

Š Renub Research

Page 3 of 5

www.renub.com

CAR T Cell Therapy Market is expected to grow with a CAGR of almost 50% in future.

5.

Geographical CAR-T Cell Therapy Market (2016 -2026) 5.1 5.2 5.3 5.4 5.5 5.6

6.

Global - CAR-T Cell Clinical Trials/Study 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 6.10

7.

Venture Capital Investment Initial Public Offerings of CAR-T Companies CAR-T Companies Strategic Partnerships/Deals Key CAR-T Technology Deals

Growth Drivers 11.1 11.2

12.

United States European Union China

IPO/Investment/Funding/Partnership in CAR-T Cell Therapy Market 10.1 10.2 10.3 10.4

11.

Strength Weakness Opportunities Threats

Regulation in CAR-T Cell Therapy 9.1 9.2 9.3

10.

By Cities CAR-T Cells Clinical Trials CD19 Directed CAR-T Cells Clinical Trials Non-CD19 Directed CAR-T Cells Clinical Trials Solid Tumors CAR-T Cells Clinical Trials

CAR-T Cell Therapy SWOT Analysis 8.1 8.2 8.3 8.4

9.

CD19 CD20 CD22 CD30 CD33 EGFRvIII GD2 HER1 HER2 MESO

China CAR-T Cells Clinical Trials Details 7.1 7.2 7.3 7.4

8.

North America Europe Asia Pacific Latin America Middle East Africa

FDA Approvals of CAR-T Therapy Dramatically Increasing Number of CAR-T Cell Trials Globally

Challenges 12.1 12.2

Regulatory Challenges Very Expensive CAR-T Therapy Treatment

© Renub Research

Page 4 of 5

www.renub.com

CAR T Cell Therapy Market is expected to grow with a CAGR of almost 50% in future.

13.

14.

15.

16.

Novartis 13.1 13.2

Company Overview Initiatives

13.3

Financial Insight

Gilead Sciences (Kite Pharma) 14.1 14.2

Company Overview Company Initiatives

14.3

Company Financial Insight

Celgene Corporation (Juno Therapeutics) 15.1 15.2

Company Overview Company Initiatives

15.3

Company Financial Insight

Celyad 16.1

Company Overview

16.2

Company Initiatives

16.3

Financial Insight

Drugs & Pharmaceuticals Market Reports: https://www.renub.com/drugs-and-pharmaceuticals-13-c.php

Renub Research - North America

Renub Research - Asia

Rajat Gupta

Ankit Mishra

225 Kristie Ln, Roswell

C – 86, Sector – 10

Georgia 30076, United States

Noida 201301, India

Tel: +1-678-302-0700

Tel: +91-120-421-9822

Email: info@renub.com

Email: info@renub.com

https://www.renub.com/

https://www.renub.com/

© Renub Research

Page 5 of 5

www.renub.com